Episode 7 - Business Insights: Sensible First Steps for Small and Emerging Biopharma Organizations

As life sciences companies continue to prioritize new, omnichannel-centric commercial and customer engagement models, the ability for small and emerging biopharma organizations (EBPs) to be nimble and agile (relative to larger pharma companies) presents a potential advantage. Because many of these organizations are not as constrained as some of their larger peers by the complexities of existing size and scale, there is an opportunity to develop these new models more quickly and effectively. However, to date, too few EBPs have truly excelled in this space. IQVIA’s Susan Kitlas, VP, Precommercial Team, and Frank Papaianni, VP, Small Pharma, join our host, Matthew Smith, Sr. Principal, New Commercial Models & Digital Health, to identify both leading practices and sensible first steps small and EBP organizations can take on their customer engagement model journeys in this episode of our Agile Brand Promotion podcast series.